MyAverix Finance
F · Healthcare
Helix BioPharma Corp. (HBP0)
Biotechnology
Helix BioPharma Corp. (HBP0) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $86.29M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HBP0
Helix BioPharma Corp. (HBP0) — FAQ
What is Helix BioPharma Corp.'s market cap?
Helix BioPharma Corp. (HBP0) has a reported market cap of $86.29M (data as of 2026-03-29).
What is HBP0's P/E ratio?
The price-to-earnings (P/E) ratio for Helix BioPharma Corp. (HBP0) is 18.00 (data as of 2026-03-29).
Does Helix BioPharma Corp. pay a dividend?
Dividend yield is not available in the current snapshot for Helix BioPharma Corp. (HBP0). Check the MyAverix Finance app for the latest dividend data.
What sector is Helix BioPharma Corp. in?
Helix BioPharma Corp. (HBP0) is classified in the Healthcare sector (Biotechnology industry).
What exchange is HBP0 listed on?
HBP0 is listed on F.
What is Helix BioPharma Corp.'s net margin?
Helix BioPharma Corp. (HBP0) reports a net margin of 0.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.